Tavilermide (CAT: I009720) is a nerve growth factor (NGF) mimetic. It is designed to mimic the biological activity of NGF, a protein that plays a critical role in the growth and survival of nerve cells. By acting as an NGF mimetic, tavilermide can bind to and activate the same receptors as NGF, promoting nerve cell growth, differentiation, and survival. This pharmacological action of tavilermide makes it a potential therapeutic agent for conditions involving nerve damage or degeneration, such as neurodegenerative diseases and peripheral neuropathies.
| Catalog Number | I009720 |
| CAS Number | 263251-78-1 |
| Synonyms | Tavilermide;3-((4S,7S,10S)-7-(4-aminobutyl)-4-((carboxymethyl)carbamoyl)-14-nitro-6,9,12-trioxo-3,4,5,6,7,8,9,10,11,12-decahydro-2H-benzo[b][1]oxa[5,8,11]triazacyclotetradecin-10-yl)propanoic acid |
| Molecular Formula | C24H32N6O11 |
| Purity | ≥95% |
| Solubility | Soluble in DMSO, not in water |
| Storage | 0 - 4 °C for short term, or -20 °C for long term |
| SMILES | O=C(O)CC[C@H](N1)C(N[C@@H](CCCCN)C(N[C@H](C(NCC(O)=O)=O)CCOC2=CC=C([N+]([O-])=O)C=C2C1=O)=O)=O |
